Bio-Rad Laboratories, Inc. BIO.B Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Bio-Rad Laboratories, Inc. (BIO.B) reported cash provided by (used in) operating activity, including discontinued operation of $108.1M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation decreased by 16.8% year-over-year, from $129.9M to $108.1M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s cash provided by (used in) operating activity, including discontinued operation has grown at a -5.6% compound annual growth rate (CAGR), from $669.46M to $532.2M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.